Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Federal Trade Commission
Queensland Health
Fish and Richardson

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020491

« Back to Dashboard
NDA 020491 describes CORVERT, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from two suppliers. Additional details are available on the CORVERT profile page.

The generic ingredient in CORVERT is ibutilide fumarate. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ibutilide fumarate profile page.

Summary for 020491

Formulation / Manufacturing:see details

Pharmacology for NDA: 020491

Suppliers and Packaging for NDA: 020491

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ibutilide fumarate
INJECTABLE;INJECTION 020491 NDA Pharmacia and Upjohn Company 0009-3794 0009-3794-44 10 mL in 1 VIAL, SINGLE-DOSE (0009-3794-44)
ibutilide fumarate
INJECTABLE;INJECTION 020491 NDA Pharmacia and Upjohn Company 0009-3794 0009-3794-22 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-3794-22) > 10 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.1MG/ML
Approval Date:Dec 28, 1995TE:APRLD:Yes

Expired Orange Book Patents for NDA: 020491

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn
ibutilide fumarate
INJECTABLE;INJECTION020491-001Dec 28, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fish and Richardson
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus